載入...
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti-dyslipidemic effects and can also ameliorate NAFLD. Thus, BBR might exert its therapeutic effect on NAFLD by improving glucoli...
Na minha lista:
| 發表在: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5329945/ https://ncbi.nlm.nih.gov/pubmed/28241817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0165-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|